Characterization of recombinant gorilla adenovirus HPV therapeutic vaccine PRGN-2009

There are approximately 44,000 cases of human papillomavirus–associated (HPV-associated) cancer each year in the United States, most commonly caused by HPV types 16 and 18. Prophylactic vaccines successfully prevent healthy people from acquiring HPV infections via HPV-specific antibodies. In order t...

Descripción completa

Detalles Bibliográficos
Autores principales: Pellom, Samuel T., Smalley Rumfield, Claire, Morillon, Y. Maurice, Roller, Nicholas, Poppe, Lisa K., Brough, Douglas E., Sabzevari, Helen, Schlom, Jeffrey, Jochems, Caroline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119209/
https://www.ncbi.nlm.nih.gov/pubmed/33651712
http://dx.doi.org/10.1172/jci.insight.141912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119209/
https://www.ncbi.nlm.nih.gov/pubmed/33651712
http://dx.doi.org/10.1172/jci.insight.141912

Ejemplares similares